登入選單
返回Google圖書搜尋
其他書名
Influenza
出版CSF Medical Communications, 2004-11
ISBN19050645279781905064526
URLhttp://books.google.com.hk/books?id=NbffAAAACAAJ&hl=&source=gbs_api
註釋Drugs in Context is an independent, peer reviewed and practice orientated review of all the significant data on a specific drug, placed in the context of the disease and clinical practice setting. Oseltamivir; Editorial: The coming years will see GPs prescribing more of the new anti-influenza drugs in primary care, both in treating the most vulnerable patients and in preventing virus spread in families and elderly residential homes. Disease Overview: The threat from influenza is greatly increased in those with other chronic underlying medical conditions, particularly cardiovascular disease, diabetes and chronic obstructive pulmonary disease. Drug Review: Reported benefits of oseltamivir treatment include faster resolution of symptoms such as cough, fever and sore throat, plus a speedier return to good health, normal sleeping patterns and a restoration of activity to pre-illness levels. Improving Practice: We can only hope that government policy may shift over the coming years to encourage the routine vaccination of more children and adults.